Orchid Pharma has announced that Mr. Mridul Dhanuka, Whole Time Director, will represent the company at an upcoming investor engagement. The group meet is scheduled to take place on April 10, 2026, in Gurugram. This physical meeting serves as a platform for investor interaction, with the company clarifying that no unpublished price-sensitive information will be disclosed during the proceedings.
Upcoming Investor Engagement
Orchid Pharma Limited has confirmed that its leadership will be actively engaging with the investment community. Mr. Mridul Dhanuka, serving as the Whole Time Director of the company, is set to participate in an investor roadshow. This session is designed to foster dialogue between the company and its stakeholders.
Meeting Details
The investor roadshow is scheduled for Friday, April 10, 2026. The event will be held as a physical group meet located in Gurugram. This engagement provides an opportunity for direct interaction, though the company noted that the schedule remains subject to change based on unforeseen exigencies.
Policy on Information Disclosure
In adherence to strict corporate governance standards, Orchid Pharma has explicitly stated that no unpublished price-sensitive information will be shared or discussed during this investor meet. This ensures that all market participants remain informed through official, public disclosure channels.
Source: BSE
